Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Oct 17, 2025 3:59:47 PM EDT

18.58USD-1.328%(-0.25)585,378

0.00Bid 0.00Ask 0.00Spread

Pre-market

Oct 17, 2025 9:27:30 AM EDT

18.71USD-0.639%(-0.12)4,114

After-hours

Oct 17, 2025 4:18:30 PM EDT

18.65USD+0.377%(+0.07)150

OverviewOptionsHistoricalExchangesShortsNews

Jan 17, 2022

05:22AM EST TNXP: The Rise of Omicron Points to Deficiencies in Current Vaccination Strategy Benzinga

Jan 11, 2022

07:02AM EST Tonix Pharmaceuticals Initiates Enrollment In Clinical Trial Of TNX-2100, A Diagnostic Skin Test To Measure Functional T Cell Immunity To SARS-CoV-2 Benzinga

07:00AM EST Potential Uses Include: Biomarker of Immunity to SARS-CoV-2; Personalized Approach to Timing COVID-19 Vaccine Boosters; Public Health Surveillance; and Serving as an Endpoint for COVID-19 Vaccine Trials GlobeNewswire Inc

Jan 5, 2022

07:00AM EST Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will participate in the H.C. Wainwright BioConnect Conference and the Biotech Showcase 2022, both being held virtually. GlobeNewswire Inc

Jan 4, 2022

07:08AM EST Tonix Pharmaceuticals Announces Exclusive Option And Research Collaboration With Kansas State University To Develop LNP-Free mRNA Vaccines Benzinga

07:00AM EST New Zinc Nanoparticle (ZNP) Technology Replaces the Lipid Nanoparticle (LNP) Technology Employed in Current mRNA COVID-19 Vaccines GlobeNewswire Inc

Jan 3, 2022

07:21AM EST The following are some of the stocks making big moves in Monday's pre-market trading (as of 07.15 A.M. ET). RTTNews

Dec 15, 2021

08:03AM EST The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO Benzinga

07:20AM EST Tonix Pharmaceuticals Added To Nasdaq Biotechnology Index Benzinga

07:00AM EST Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI) as part of the Nasdaqs annual reconstitution process. The addition will become effective prior to market open on Monday, December 20, 2021. GlobeNewswire Inc

Dec 14, 2021

07:21AM EST Tonix Pharmaceuticals Announces IND Clearance For Skin Test (TNX-2100) To Measure SARS-CoV-2 Exposure And T Cell Immunity Benzinga

07:00AM EST First-in-Human Study Expected to be Initiated in the First Quarter of 2022 GlobeNewswire Inc

Dec 13, 2021

10:53AM EST FMW Medias New to The Street T.V. announces the broadcastings of its nationally syndicated shows, tonight, Monday, December 13, 2021,at 10:30 PM P.T. and tomorrow night, Tuesday, December 14, 2021,at 10:30 PM PT on Fox Business Network. GlobeNewswire Inc

07:16AM EST Tonix Pharmaceuticals Announces Research Collaboration With Columbia University To Study Recombinant Trefoil Factor 2 Based Therapy For Gastric And Colorectal Cancers Benzinga

07:00AM EST TNX-1700 is Under Development as Monotherapy and in Combination with Anti-PD1 Checkpoint Inhibitor Therapy in Animal Models of Two Challenging Cancers GlobeNewswire Inc

Dec 10, 2021

09:00AM EST FMW Medias New to The Street/ Newsmax TV announces the broadcasting line-up of its national syndicated TV show this Sunday, December 12, 2021, airing 1011 A.M. ET. GlobeNewswire Inc

Dec 1, 2021

10:03AM EST Tonix Pharmaceuticals Tweets OpEd Written By Co's CEO On Omicron Variant Benzinga

Nov 23, 2021

08:10AM EST The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug Benzinga

07:10AM EST Tonix Pharma Announces FDA Clearance Of IND For TNX-1900 For Prevention Of Migraine Headache In Chronic Migraineurs RTTNews

07:04AM EST Tonix Pharmaceuticals Announces FDA Clearance Of IND For Potentiated Intranasal Oxytocin (TNX-1900) For Prevention Of Migraine Headache In Chronic Migraineurs Benzinga

07:00AM EST Tonix Pharmaceuticals Announces FDA Clearance of the IND for GlobeNewswire Inc

Nov 22, 2021

04:09PM EST Tonix Pharmaceuticals Announces Publication Of Paper On Antiviral SARS-CoV-2 Inhibitor, TNX-3500, In JCI Insight Benzinga

04:05PM EST Tonix Pharmaceuticals Announces Publication of Paper on Antiviral GlobeNewswire Inc

Nov 15, 2021

10:53AM EST Tonix Pharmaceuticals Announces Issuance Of US Patent For Use Of TNX-1700, A Stabilized Recombinant Form Of Trefoil Factor 2 (TFF2), For Treating Gastric And Pancreatic Cancers Benzinga

07:00AM EST Tonix Pharmaceuticals Announces Issuance of U.S. Patent for Use of GlobeNewswire Inc

Nov 12, 2021

07:00AM EST Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will present at the Q4 Investor Summit on November 17, 2021, at 4:50 p.m. ET. GlobeNewswire Inc

Nov 9, 2021

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:34AM EST Tonix Pharmaceuticals Presents Phase 1 Formulation Development Data For TNX-601 CR In A Poster Presentation At CNS Summit 2021 Benzinga

11:08AM EST Tonix Pharma Highlights Presentation of Phase 3 RELIEF Study Of TNX-102 SL For Mgmt. Of Fibromyalgia At American College Of Rheumatology Convergence Benzinga

07:00AM EST Tonix Pharmaceuticals Presents Phase 1 Formulation Development GlobeNewswire Inc

Nov 8, 2021

04:05PM EST Tonix Pharmaceuticals Presents Positive Results from Phase 3 GlobeNewswire Inc

07:17AM EST Tonix Pharmaceuticals Q3 EPS $(0.05) Up From $(0.09) YoY Benzinga

07:00AM EST Expansion of Internal Research and Development Capabilities Underway to Accelerate Infectious Disease Programs and Prepare for Future Pandemic Responses GlobeNewswire Inc

Nov 3, 2021

01:38PM EDT Tonix Tweets 'Tonix Pharmaceuticals CMO Dr. Gregory Sullivan will present results from the RELIEF study at this year's @ACRheum Convergence 2021. This positive Phase 3 study investigated the use of TNX-102 SL for the management of #fibromyalgia.' Benzinga

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 21, 2021

07:00AM EDT Tonix Pharmaceuticals to Participate in BIO-Europe Digital 2021 GlobeNewswire Inc

Oct 15, 2021

07:00AM EDT Internal R&D Capabilities Expected to Support U.S. Pandemic Preparedness with Accelerated Discovery and Development of Vaccines and Antivirals Against COVID-19 and Other Infectious Diseases GlobeNewswire Inc

Oct 14, 2021

09:15AM EDT FMW Media's New to The Street T.V. announces the 248th T.V. broadcasting of its national syndicated show, Thursday, October 14, 2021, at 10:30 P.M. P.T. on Fox Business Network, featuring the following four Companies and their businesses representatives: GlobeNewswire Inc

Oct 7, 2021

07:00AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, has been invited to participate in a panel discussion at the A.G.P. Fall Virtual Biotech & Specialty Pharma Conference on October 13, 2021. GlobeNewswire Inc

Oct 4, 2021

11:45AM EDT FMW Medias New to The Street TV announces the broadcastings of its national syndicated showstonight, Monday, October 4, 2021at 10:30 PM PT and tomorrow, Tuesday night, October 5, 2021at 10:30 PM PT on Fox Business Network. GlobeNewswire Inc

07:00AM EDT R&D Center is Expected to Accelerate Internal Discovery and Development of Vaccines and Antiviral Drugs Against COVID-19, its Variants and Other Infectious Diseases GlobeNewswire Inc

Oct 1, 2021

12:30PM EDT FMW Medias New to The Street/ Newsmax TV announces the broadcasting line-up of its national syndicated 1-hour TV show this Sunday, October 3, 2021, airing time 10-11 AM ET. GlobeNewswire Inc

Sep 27, 2021

07:00AM EDT Tonix Pharmaceuticals Announces Oral Presentation at the American GlobeNewswire Inc

Sep 23, 2021

07:01AM EDT Tonix Pharmaceuticals Expands Research Collaboration With Columbia University To Develop Precision Medicine Techniques For COVID-19 Vaccines And Therapeutics Benzinga

07:00AM EDT Collaboration Will Continue to Work Towards Identifying Biomarkers for Protective Immunity Against SARS-CoV-2 GlobeNewswire Inc

Sep 22, 2021

07:00AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at the 2021 Cantor Virtual Global Healthcare Conference on September 28, 2021, at 2:00 p.m. ET. GlobeNewswire Inc

Sep 14, 2021

12:25PM EDT For COVID-19, Live Virus Vaccines Could Give Longer Term Protection Than the Current Warp Speed Vaccines But They're Not Here Yet Benzinga

Sep 13, 2021

09:45AM EDT Tonix Pharma Shares FDA Response For COVID-19 Vaccine Candidate Human Study Benzinga

08:03AM EDT Tonix Pharmaceuticals Announces Results Of Pre-IND Meeting With FDA For TNX-1800 As A Potential Vaccine To Prevent COVID-19; Says Phase 1 Trial Expected To Start In 1H Of 2022 Benzinga

08:01AM EDT TNX-1800 is a Live Virus Vaccine Designed to Elicit Durable T cell Immunity GlobeNewswire Inc

Sep 7, 2021

07:00AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually September 13-15, 2021. GlobeNewswire Inc

Aug 31, 2021

02:03PM EDT Tonix Pharmaceuticals Shares Quiet; Alliance Global Partners Reiterates Buy Rating Benzinga

Aug 24, 2021

10:12AM EDT TNXP: Multiple COVID Programs and Building Domestic Vaccine Research Infrastructure Benzinga

08:09AM EDT The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal Benzinga

08:00AM EDT Tonix Pharmaceuticals Holding Corp. (TNXP) on Tuesday said it received official minutes from the pre-IND meeting with FDA to develop TNX-102 SL as a potential treatment for Long COVID Syndrome. RTTNews

07:11AM EDT Tonix Reports Results Of Pre-IND Meeting For TNX-102 SL As Potential Treatment For COVID Syndrome RTTNews

07:04AM EDT Tonix Pharmaceuticals Announces Results Of Pre-IND Meeting With FDA For TNX-102 SL As A Potential Treatment for Long COVID Syndrome; Based On Minutes, Co. Plans To Submit IND In Q4 OD 2021 Benzinga

07:00AM EDT Company Plans to Submit an IND to Support a Phase 2 Clinical Trial of TNX-102 SL for the Treatment of Long COVID GlobeNewswire Inc

Aug 9, 2021

05:28PM EDT Tonix Pharmaceuticals Q2 EPS $(0.07) Up From $(0.23) YoY Benzinga

08:57AM EDT Tonix Pharmaceuticals Sponsored Study Titled 'An Open-Label, Randomized Pilot Study Comparing the Safety of a Single Dose of TNX-1300...' Posted To Clinical Trials Website; Study Not Yet Recruiting Benzinga

Aug 6, 2021

03:51PM EDT FMW Medias New to The Street TV broadcasting its national syndicated show, Monday, August 09, 2021 at 10:30 PM PT and Tuesday, August 10, 2021 at 10:30PM PT on Fox Business Network. GlobeNewswire Inc

10:38AM EDT FMW Medias New to The Street TV announces the broadcasting of its business TV show, Saturday, August 7, 2021 on Bloomberg TV at 4:30 PM ET. GlobeNewswire Inc

Aug 2, 2021

07:00AM EDT Tonix Pharmaceuticals Announces Groundbreaking Ceremony for GlobeNewswire Inc

Jul 27, 2021

11:13AM EDT The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts Benzinga

11:13AM EDT Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs Benzinga

Jul 26, 2021

02:32PM EDT Mid-Afternoon Market Update: Dow Rises 50 Points; Iterum Therapeutics Shares Slide Benzinga

12:10PM EDT Mid-Day Market Update: Crude Oil Down 1%; Xenetic Biosciences Shares Spike Higher Benzinga

06:41AM EDT IDMC Recommends Tonix Pharma To Stop Enrollment In Fibromyalgia Trial; Shares Drop Benzinga

Jul 23, 2021

11:40PM EDT Tonix Pharmaceuticals Holding Corp. (TNXP) said that it has decided to stop enrollment in the Phase 3 RALLY study of TNX-102 SL --cyclobenzaprine HCl sublingual tablets-- 5.6 mg for the management of fibromyalgia. RTTNews

06:21PM EDT FMW Medias New to The Street TV announces the broadcasting of its business TV show, Friday, July 23, 2021 onBloomberg TVat 9:30 PM PT. GlobeNewswire Inc

04:48PM EDT Tonix Pharmaceuticals Shares Set To Resume Trading At 5:10 p.m. EDT; Shares Were Halted Earlier On Code News Pending Benzinga

04:45PM EDT Tonix Pharmaceuticals Highlights Interim Analysis Of Phase 3 RALLY Study Of TNX-102 SL For The Management Of Fibromyalgia Benzinga

04:40PM EDT RALLY Study Will Stop Enrolling New Participants Following Recommendation from an Interim Analysis Indicating Inadequate Separation from Placebo at Week-14 in the First 50% of Participants, Based on the Original Targeted Study Size GlobeNewswire Inc

Jul 19, 2021

07:00AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix), a clinical-stage biopharmaceutical company, today announced the appointment of Carolyn E. Taylor to its Board of Directors, effective as of July 16, 2021. GlobeNewswire Inc

Jun 28, 2021

07:12AM EDT Tonix Pharmaceuticals Added to Russell 2000 and Russell 3000 Indexes Benzinga

07:00AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Tonix was added to the broad-market Russell 3000 index and the small-cap Russell 2000Index, effective after the U.S. market opens today, June 28, 2021, as part of the annual reconstitution of the Russell stock indexes. GlobeNewswire Inc

Jun 26, 2021

01:00PM EDT FMW Medias New To The Street /Newsmax TV announces this weeks, Sunday, June 27, 2021, broadcasting line-up of its national syndicated 1- hour show, 10-11AM ET. GlobeNewswire Inc

Jun 25, 2021

03:50PM EDT FMW Medias New to The Street TV announces the broadcasting of its business TV show, Saturday, June 26, 2021 on Bloomberg TV at 6:00 PM ET. GlobeNewswire Inc

08:56AM EDT Tonix Pharma Stock Moving Higher On Plans For Vaccine Manufacturing Facility In Bitterroot Valley Benzinga

Jun 21, 2021

08:01AM EDT Tonix Pharmaceuticals Holding Corp. (TNXP) said that it plans to develop TNX-102 SL or cyclobenzaprine HCl sublingual tablets as a potential treatment for Long COVID Syndrome which is now known officially as Post-Acute Sequelae of COVID-19 or PASC. RTTNews

07:48AM EDT Tonix Pharma To Test Its Fibromyalgia Candidate In Long COVID Syndrome Benzinga

07:13AM EDT Tonix Plans To Develop TNX-102 SL As A Potential Treatment For Long COVID Syndrome RTTNews

07:03AM EDT Tonix Pharmaceuticals Announces Program to Develop TNX-102 SL for the Treatment of Long COVID Syndrome, also Known as Post-Acute Sequelae of COVID-19 Benzinga

07:00AM EDT Long COVID Symptoms of Pain, Sleep Disturbance, Fatigue and Brain Fog Overlap with Symptoms of Fibromyalgia, for which TNX-102 SL is in Mid-Phase 3 Development GlobeNewswire Inc

Jun 18, 2021

12:43PM EDT FMW Medias New To The Street /Newsmax TV announces this weeks, Sunday, June 20, 2021, broadcasting line-up of its national syndicated 1-hour show, 10-11AM ET. GlobeNewswire Inc

Jun 16, 2021

07:00AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at the Raymond James Human Health Innovation Conference on June 23, 2021, at 8:00 a.m. ET. GlobeNewswire Inc

Jun 10, 2021

07:00AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will participate in the BIO Digital Conference being held June 10-11 and 14-18, 2021. GlobeNewswire Inc

Jun 8, 2021

03:28PM EDT Tonix Pharma Holdings Limited Granted Patent On Eutectic Formulations Of Cyclobenzaprine Hydrochloride Benzinga

Jun 4, 2021

11:51AM EDT TNXP: Interim Analysis for Phase 3 RALLY Trial in 3Q21; Topline Results in 1Q22 Benzinga

Jun 3, 2021

08:37AM EDT Tonix Pharma Fibromyalgia Treatment Associated with Improvement in Pain, Sleep, Fatigue Benzinga

07:17AM EDT Tonix Pharmaceuticals Presents Positive Results from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the 2021 American Society of Clinical Psychopharmacology Annual Meeting Benzinga

07:00AM EDT Tonix Pharmaceuticals Presents Positive Results from Phase 3 GlobeNewswire Inc

May 26, 2021

07:00AM EDT Tonix Pharmaceuticals Announces Presentation of Two Posters at the GlobeNewswire Inc

May 12, 2021

07:00AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will present a company overview during the Q2 Investor Summit Virtual Conference on Monday, May 17, 2021 at 3:30 p.m. ET. GlobeNewswire Inc

May 10, 2021

04:54PM EDT Tonix Pharmaceuticals Q1 EPS $(0.07) Up From $(0.37) YoY Benzinga

04:30PM EDT Announced Positive Efficacy Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800 GlobeNewswire Inc

Apr 24, 2021

03:49PM EDT FMW Medias New to The Street TV broadcast its no. 170 show today on Bloomberg Television at 6 PM EST. And, broadcasting its 1- hour show tomorrow, April 25, 2021, on NEWSMAX TV from 10-11AM EST. GlobeNewswire Inc

Apr 21, 2021

07:00AM EDT Tonix Pharmaceuticals to Participate in Fourth Annual Neuroscience GlobeNewswire Inc

Apr 19, 2021

07:52AM EDT Tonix Pharma Stock Is Trading Higher On Expanding COVID-19 Candidate Portfolio With Sangivamycin Licensing Pact Benzinga

07:10AM EDT Tonix Enters Exclusive Worldwide Licensing Agreement With OyaGen RTTNews

07:01AM EDT Tonix Pharmaceuticals Enters Exclusive Worldwide Licensing Agreement With OyaGen To Develop Antiviral SARS-CoV-2 Inhibitor, TNX-3500, For The Treatment Of COVID-19; Financial Terms Not Disclosed Benzinga

07:00AM EDT Tonix Pharmaceuticals Enters into Exclusive Worldwide Licensing GlobeNewswire Inc

Apr 7, 2021

09:47AM EDT Tonix Pharma Shares Relatively Quiet But See Spike In Volume Following Tweet From Zacks Small Cap Research '$TNXP: @TonixPharma - One Dose COVID Vaccine Effective in Non Human Primate Model - https://bit.ly/3uuusVx by @DavidBautz' Benzinga

07:00AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will present a company overview during the 20th Annual Needham Virtual Healthcare Conference on Wednesday, April 14, 2021 at 8:00 a.m. ET. GlobeNewswire Inc

Mar 25, 2021

10:57AM EDT Insider Buys Tonix Pharmaceuticals Stock Benzinga

Mar 22, 2021

02:30PM EDT Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with GlobeNewswire Inc

Mar 19, 2021

07:04AM EDT Tonix Pharma Reports US Patent & Trademark Office Patent Issued For No. 10,946,027 To Co. For 'Compositions and Uses of Tianeptine Oxalate Salt, the Active Ingredient of TNX-601 CR' Benzinga

07:00AM EDT Tonix Pharmaceuticals Announces Issuance of U.S. Patent for GlobeNewswire Inc

Mar 17, 2021

09:35AM EDT Tonix Pharma's COVID-19 Vaccine Candidate Shows Encouraging Efficacy In Animal Studies Benzinga

07:43AM EDT The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes Benzinga

07:06AM EDT Tonix Pharmaceuticals Reports COVID-19 Vaccine Efficacy Results In Non-Human Primates Vaccinated With TNX-1800 And Challenged With Live SARS-CoV-2; Says TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2 Benzinga

07:00AM EDT Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission GlobeNewswire Inc

Mar 16, 2021

07:00AM EDT EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies announces the Schedule of the 3rd Emerging Growth Conference. GlobeNewswire Inc

Mar 15, 2021

04:46PM EDT Tonix Pharmaceuticals Q4 EPS $(0.10) Up From $(2.86) YoY Benzinga

04:45PM EDT Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia GlobeNewswire Inc

07:17AM EDT Tonix Pharma Achieves 50% Enrollment In RALLY; Sees Topline Results Of About 670 Participants In RALLY In Q4 RTTNews

07:06AM EDT Tonix Pharma Announces 50% Enrollment in its Second Phase 3 Study of TNX-102 to Treat Fibromyalgia Benzinga

07:00AM EDT Enrollment Continues in Phase 3 RALLY Study, with Interim Analysis of the First 50 Percent of Participants Expected Third Quarter 2021 GlobeNewswire Inc

Mar 9, 2021

07:30AM EST Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will participate in the following upcoming virtual investor conferences. GlobeNewswire Inc

Mar 4, 2021

07:00AM EST Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid GlobeNewswire Inc

Feb 12, 2021

11:01AM EST Why Tonix Pharma Is Trading Higher Today Benzinga

Feb 11, 2021

07:00AM EST Expands Proprietary Uses of Tonixs Potentiated Oxytocin for Intranasal Administration GlobeNewswire Inc

Feb 10, 2021

07:00AM EST Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will participate in the BIO CEO & Investor Digital Conference being held February 16-18, 2021. GlobeNewswire Inc

Feb 9, 2021

04:05PM EST Tonix Pharmaceuticals Holdings Corp. Closes $70M Common Stock GlobeNewswire Inc

01:47AM EST ATHE Gets Funded For Parkinson's Research, No Safety RTTNews

Feb 8, 2021

01:15PM EST Tonix Pharmaceuticals $70M; Plans To Develop COVID-19 Skin Test Benzinga

10:30AM EST Tonix Pharma Prices 58.3M Share Offering At $1.20/Share Benzinga

10:30AM EST Tonix Pharmaceuticals Holdings Corp. Prices $70M Common Stock GlobeNewswire Inc

07:02AM EST Tonix Pharmaceuticals Receives Pre-IND Meeting Written Response From FDA Providing Guidance On Product Development And Clinical Testing Protocol For COVID-19 Skin Test Benzinga

07:00AM EST Pre-IND Meeting Written Response from FDA Provides Guidance on Product Development and Clinical Testing Protocol GlobeNewswire Inc

Feb 3, 2021

02:31PM EST 'PATENT $TNXP Tonix Pharmaceuticals received a Notice of Allowance on 2/1 from the US Patent and Trademark Office for Application No. 16/518,338, titled: EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE.' - PatentEagle Benzinga

10:41AM EST Tonix Pharmaceuticals Shares Quiet; Co Tweets 'At the recent @Benzinga Global Small Cap Conference, Dr. Seth Lederman, CEO discussed $TNXP's two #COVID19 #vaccines being developed for long-term #immunity, the importance of having multiple vaccine options' Benzinga

Jan 14, 2021

07:06AM EST Tonix Pharmaceuticals Announces Publication of Patent Application for TNX-1500 in Development for Preventing and Treating Organ Transplant Rejection and Treating Autoimmune Conditions Benzinga

07:00AM EST GMP Production of TNX-1500 is Expected to be Available in the Third Quarter of 2021 GlobeNewswire Inc

Jan 13, 2021

04:05PM EST TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP)(Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced registered direct offering, priced at-the-market, with gross proceeds of $40.0 million before deducting fees and other estimated offering expenses. GlobeNewswire Inc

Jan 11, 2021

01:01PM EST Tonix Pharmaceuticals Shares Drop; Co Prices $40M Offering Priced At-The-Market Benzinga

01:00PM EST Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock GlobeNewswire Inc

10:12AM EST 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Jan 5, 2021

04:15PM EST Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at four upcoming virtual conferences in January. GlobeNewswire Inc

08:39AM EST The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data Benzinga

07:16AM EST Tonix Pharmaceuticals And Massachusetts General Hospital Enter Into Research Collaboration On Tonix's Third Generation Anti-CD40-Ligand Monoclonal Antibody, TNX-1500, For Treatment And Prevention Of Kidney Transplant Rejection Benzinga

07:12AM EST Tonix Pharma, MGH Enter Research Collaboration On TNX-1500 For The Treatment Of Kidney Transplant Rejection RTTNews

07:00AM EST Expands Ongoing Research Collaboration Between Tonix and MGH Studying TNX-1500 in Heart Transplantation GlobeNewswire Inc

Jan 4, 2021

05:04PM EST Tonix Pharmaceuticals CEO Seth Lederman Bought 35,000 Shares @ Avg Price: $0.68/Share Benzinga

05:03PM EST Tonix Pharmaceuticals Holding Corp.: LEDERMAN SETH (Director, Chief Executive Officer) Buys 35,000 @ Avg Price: $0.68 (Form4) Benzinga

Dec 23, 2020

09:02AM EST Tonix Pharma Reports Completion Of Purchase Of ~44-Acre Site In Hamilton, Montana For Construction Of Vaccine Development, Commercial Scale Manufacturing Facility, No Terms Disclosed Benzinga

09:00AM EST Hamilton, MT Facility Is Planned to Manufacture Vaccines at Commercial Scale, Including Vaccines Under Development for COVID-19 GlobeNewswire Inc

Dec 22, 2020

07:45AM EST The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes Benzinga

07:01AM EST Tonix Pharmaceuticals Acquires Exclusive License To University Of Geneva Technology For Oxytocin-Based Treatments For Treating Insulin Resistance, Diabetes And Obesity Benzinga

07:00AM EST Tonix Pharmaceuticals Acquires Exclusive License to University of GlobeNewswire Inc

Dec 21, 2020

11:05AM EST Tonix : Phase 3 Study On Posttraumatic Stress Disorder RTTNews

07:16AM EST Tonix Pharmaceuticals Reports Results from Phase 3 RECOVERY Study of TNX-102 SL in PTSD Did Not Achieve Statistical Significance In The Prespecified Primary Efficacy Endpoint Benzinga

07:05AM EST Tonix Pharma Says Phase 3 RECOVERY Study Of TNX-102 SL Fails To Achieve Statistical Significance RTTNews

07:00AM EST Primary Endpoint For Full Cohort of Enrolled Participants Did Not Achieve Statistical Significance (P=0.343), Consistent with Previously Reported Interim Analysis GlobeNewswire Inc

Dec 18, 2020

04:44PM EST Tonix Pharmaceuticals Holding Corp Files For Mixed Shelf Of Up To $150M Benzinga

Dec 9, 2020

10:38AM EST From BZ Small Cap Event: Tonix CEO Sees Data On Next Step For COVID-19 Candidate In Q1'21 Benzinga

10:34AM EST From BZ Small Cap Event: Tonix CEO Highlights Its COVID-19 Candidate Is 'Engineered For Long-Term Immunity' Benzinga

10:33AM EST From BZ Small Cap Event: Tonix CEO Says Tonix Is One Of Only A Few Working On Live Attenuated Viruses As Potential Treatment For COVID-19 Benzinga

10:32AM EST From BZ Small Cap Event: Tonix CEO Now Discussing Potential COVID-19 Treatment Via Horsepox Virus Vector Benzinga

10:32AM EST From BZ Small Cap Event: Tonix CEO Sees Results From Ongoing TNX-102 Second Potential Pivotal Phase 3 Study In H2'21 Benzinga

10:28AM EST From BZ Small Cap Event: Tonix CEO Sees Submitting New Druga Application For Fibromyalgia Candidate In 2021 Benzinga

10:27AM EST From BZ Small Cap Event: Tonix CEO Highlighting Co.'s Two Areas To Focus Development: Central Nervous System, Immunology Benzinga

10:26AM EST From BZ Small Cap Event: Tonix CEO Seth Lederman Beginning Presentation Benzinga

10:21AM EST Tonix Pharma CEO Seth Lederman To Present At Benzinga's Small Cap Event In Next Few Mins Benzinga

Dec 7, 2020

05:22PM EST Schedule Of NYSE-, Nasdaq-Listed Publicly-Traded Companies Presenting At Benzinga's Small Cap Conference Dec. 8-9 Benzinga

07:15AM EST Tonix Pharma Announces Positive Phase 3 RELIEF Study Results For TNX-102 SL 5.6 Mg In Fibromyalgia RTTNews

07:12AM EST Tonix Pharmaceuticals Announces Results From Phase 3 RELIEF Study for TNX-102 SL 5.6 mg in Fibromyalgia Met Its Pre-Specified Primary Endpoint Benzinga

07:00AM EST New 5.6 mg Dose Achieved Statistically Significant Pain Reduction Over Placebo at Week 14 (Primary Endpoint, p=0.01) GlobeNewswire Inc

Dec 4, 2020

08:03AM EST Tonix Pharma Highlights Independent Researchers Reported 99.7% Colinear Identity Between A Circa 1860 US Smallpox Vaccine And Horsepox Virus Benzinga

08:00AM EST Vaccine Genome Researchers Report 99.7% Colinear Identity Between GlobeNewswire Inc

Nov 16, 2020

09:48AM EST A Look Into Healthcare Sector Value Stocks Benzinga

07:09AM EST Tonix Pharmaceuticals Reports Positive Immune Response Results from COVID-19 Vaccine Candidate TNX-1800, Following Vaccination of Non-Human Primates Benzinga

07:00AM EST Anti-SARS-CoV-2 Neutralizing Antibodies Elicited in All Eight TNX-1800 Vaccinated Animals GlobeNewswire Inc

Nov 12, 2020

04:38PM EST Tonix Pharmaceuticals Highlights Presentation Of New Statistical Method To Analyze Future PTSD Studies At 3rd Annual Neuropsychiatric Drug Development Summit Benzinga

04:37PM EST Tonix Pharma Offers Outline Of New Statistical Method To Analyze Future Post-Traumatic Stress Disorder Studies At Annual Neuropsychiatric Drug Development Summit Benzinga

Nov 11, 2020

07:00AM EST Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, has been invited to present at three upcoming virtual investor conferences in November. GlobeNewswire Inc

Nov 9, 2020

08:49AM EST Tonix Pharmaceuticals Q3 EPS $(0.09) Up From $(5.69) YoY Benzinga

08:30AM EST Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800, Expected in Fourth Quarter 2020 GlobeNewswire Inc

Nov 2, 2020

10:11AM EST 5 Value Stocks In The Healthcare Sector Benzinga

Oct 15, 2020

07:05AM EDT Tonix Pharmaceuticals Enrolls First Participant In PRECISION Study, An Observational Study To Facilitate Development Of Precision Medicine Techniques For COVID-19 Vaccines And Therapeutics Benzinga

07:00AM EDT Study May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics GlobeNewswire Inc

Oct 7, 2020

07:00AM EDT Tonix Pharmaceuticals to Participate in BIO Investor Forum Digital GlobeNewswire Inc

Sep 29, 2020

04:06PM EDT Tonix Pharmaceuticals Announces Plan To Complete Phase 3 RELIEF Study Of TNX-102 SL For Management Of Fibromyalgia With Currently Enrolled Participants Based On Results Of Interim Analysis Benzinga

04:05PM EDT Tonix Pharmaceuticals Announces Plan to Complete the Phase 3 GlobeNewswire Inc

Sep 28, 2020

04:16PM EDT Tonix Pharmaceuticals Completes Purchase of Facility To House Advanced Development Center For Vaccine Programs Benzinga

04:15PM EDT Facility Addresses the Shortage of Vaccine Production Capacity in the U.S. GlobeNewswire Inc

Sep 17, 2020

09:20AM EDT Tonix Pharma Will Host Live Webinar On Thursday, Sept. 24, 2020 At 10 a.m. EDT 'Antibody vs. T Cell Immunity: Is a Single Vaccine Enough to Stop COVID-19?' Benzinga

09:18AM EDT Webinar to be Moderated by Clive Cookson of the Financial Times on September 24, 2020 GlobeNewswire Inc

Sep 15, 2020

09:01AM EDT Tonix Pharmaceuticals Enrolls First Patient In COV-LOGIC, An Observational Study To Assess Antibody And T Cell Responses To Coronavirus Benzinga

09:00AM EDT Tonix Pharmaceuticals Enrolls First Patient in COV-LOGIC, an GlobeNewswire Inc

Sep 4, 2020

09:05AM EDT Tonix Pharmaceuticals Announces $30.0M Purchase Agreement With Lincoln Park Capital Benzinga

Sep 3, 2020

09:05AM EDT Tonix Pharmaceuticals Initiates Enrollment In Second Potentially Pivotal Phase 3 Study Of TNX-102 SL For Management Of Fibromylagia; Topline Results Expected In Q4 2020 Benzinga

09:01AM EDT Interim Analysis Results from Ongoing Phase 3 RELIEF Study Expected in September; Topline Results Expected in Fourth Quarter 2020 GlobeNewswire Inc

Sep 1, 2020

11:22AM EDT Insider Buys Tonix Pharmaceuticals's Stock Benzinga

Aug 27, 2020

07:30AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, has been invited to present a Company overview during the following September investor conferences. GlobeNewswire Inc

Aug 26, 2020

09:21AM EDT With Key Data Nearing, Tonix Looks to Spotlight Robust Pipeline In Immunology And CNS Therapeutics Benzinga

Aug 24, 2020

11:37AM EDT Insider Buys Tonix Pharmaceuticals Shares Benzinga

Aug 19, 2020

11:39AM EDT Insider Buys Tonix Pharmaceuticals Stock Benzinga

Aug 17, 2020

02:55PM EDT Proactive, the digital financial news organization, will be showcasing four leading-edge tech, online gaming and biopharma businesses via its North American virtual investor conference. GlobeNewswire Inc

Aug 10, 2020

08:52AM EDT Tonix Pharmaceuticals Q2 EPS $(0.23) Up From $(0.95) YoY Benzinga

08:45AM EDT Preclinical data for TNX-1800, a Vaccine Candidate to Protect Against COVID-19, Expected in Fourth Quarter 2020 GlobeNewswire Inc

Aug 6, 2020

10:11AM EDT Tonix Pharmaceuticals Announces Clearance Of IND For TNX-102 SL For Treatment Of Alcohol Use Disorder Benzinga

Aug 4, 2020

09:04AM EDT Tonix Pharma Reports Regained Compliance With Nasdaq Minimum Bid Price Requirement Benzinga

09:00AM EDT Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid GlobeNewswire Inc

07:31AM EDT Tonix Pharmaceuticals Announces That Results From Preclinical Study Of TNX-1900 Are Posted At AAN Sports Concussion Virtual Conference Benzinga

07:00AM EDT Tonix Pharmaceuticals Announces that Results from a Preclinical GlobeNewswire Inc

Jul 30, 2020

07:00AM EDT Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will deliver a Company presentation during the SNN Network Virtual Investor Conference on Thursday, August 6, 2020, at 10:00 a.m. ET. GlobeNewswire Inc

Jul 27, 2020

07:13AM EDT Tonix Pharmaceuticals To Report Results From Preclinical Study Of TNX-1900 Will Be Presented At AAN Sports Concussion Virtual Conference Benzinga

07:00AM EDT Tonix Pharmaceuticals Announces that Results from a Preclinical GlobeNewswire Inc

Jul 21, 2020

04:45PM EDT Tonix Pharmaceuticals Holding Corp. Announces Rescheduling of GlobeNewswire Inc

04:45PM EDT 04:45 Tuesday, July 21, 2020 RTTNews

10:23AM EDT Shares of Tonix Pharmaceuticals Holding Corp. (TNXP), a New York-based biopharmaceutical company, are surging more than 38 percent or $0.59 in Tuesday's morning trade at $2.14 despite no company-specific news influencing the stock. RTTNews

Jul 16, 2020

09:14AM EDT Tonix Enters Research Collaboration And Option Agreement With Columbia University RTTNews

09:01AM EDT Tonix Pharmaceuticals Announces Research Collaboration To Develop Precision Medicine Techniques For Coronavirus Vaccines, Therapeutics Benzinga

09:00AM EDT Dissecting the Immune Response to SARS-CoV-2 in Healthy Recovered or Asymptomatic Volunteers May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics GlobeNewswire Inc

Jul 15, 2020

05:00PM EDT TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ: TNXP)(Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced registered direct offering, with gross proceeds of approximately $10.5 million before deducting fees and other estimated offering expenses. GlobeNewswire Inc

Jul 13, 2020

01:13PM EDT Tonix Pharmaceuticals Prices $10.5M Offering At $0.5/Share Benzinga

01:12PM EDT Tonix Pharmaceuticals Holding Corp. Prices $10,500,000 Common GlobeNewswire Inc

07:15AM EDT Tonix Enters Research And Exclusive License Option Agreement With Kansas State University RTTNews

07:07AM EDT Tonix Pharma to Work with Kansas State University to Develop a COVID-19 Vaccine Candidate Benzinga

07:00AM EDT Research to Develop Live Replicating Vaccine (TNX-2300) to Protect Against COVID-19 Based on Bovine Parainfluenza Virus GlobeNewswire Inc